SEI Trust Company’s Puma Biotechnology PBYI Stock Holding History

SEI Trust Company’s Portfolio PBYI Stock Details PBYI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q3	$1.3M	Buy	5,445 +4,985	+1,084%	+$1.02M	0.01%	816
2014 Q2	$30K	Hold	460	–	–	﹤0.01%	1604
2014 Q1	$48K	Sell	460 -179	-28%	-$21K	﹤0.01%	1549
2013 Q4	$66K	Buy	+639	New	+$37.5K	﹤0.01%	1565

Other funds holding PBYI

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Lord, Abbett & Co Jersey City, New Jersey $30.6B AUM 57.44% 1-Year Est. Return

SEI Trust Company's PBYI Position: Q3 2014 in Review

SEI Trust Company increased its Puma Biotechnology (PBYI) stake by 1,084% in Q3 2014, buying an estimated $1.02M and bringing the position to 5,445 shares worth $1.3M. The position accounts for 0.01% of the portfolio, ranked #816.

SEI Trust Company first reported a position in PBYI in Q4 2013 and has held it in 4 quarters since. 184 funds tracked by Wall St. Rank hold PBYI as of Q3 2014.

SEI Trust Company held 5,445 shares of Puma Biotechnology worth $1.3M as of Q3 2014.
SEI Trust Company bought 4,985 Puma Biotechnology shares in Q3 2014, an estimated $1.02M.
Puma Biotechnology made up 0.01% of SEI Trust Company's portfolio in Q3 2014, its #816 holding.
SEI Trust Company first reported a position in Puma Biotechnology in Q4 2013 and has held it in 4 quarters since.
184 funds tracked by Wall St. Rank held Puma Biotechnology as of Q3 2014.

Based on SEI Trust Company's 13F filing for Q3 2014, filed 28 Oct 2014.